Beovu Lawsuit | 2025 Latest Updates

Beovu Lawsuit Overview

Recent Beovu lawsuits allege that Novartis failed to adequately warn patients that use of Beovu could result in vision loss, blindness, and other serious complications. Former Beovu users have been diagnosed with vision-related problems including retinal vasculitis, retinal artery occlusion, inflammation, and more. A Novartis safety review committee identified a rate of 4.6% intraocular inflammation associated with Beovu injections, with 2.1% of patients developing occlusive vasculitis.

Latest Beovu Lawsuit Updates

• September 2020 – The European Medicines Agency approved an update to the Beovu Summary of Product Characteristics to include warnings about retinal vasculitis and retinal vascular occlusion. Novartis announced this followed their commitment to pursue worldwide label updates after reviewing post-marketing safety events [1].
• August 2020 – A study published in JAMA Ophthalmology described the case of a 77-year-old woman who suffered acute visual acuity loss in her right eye following her second Beovu injection, developing visual acuity of 20/200 OU [2].
• July 2020 – A study published in the Journal of VitreoRetinal Diseases found that retinal vasculitis had been identified in multiple patients who had recently undergone Beovu injections, with researchers noting that some eyes had significant vision loss [3].
• May 2020 – An editorial piece published in the American Journal of Ophthalmology opined that use of Beovu injections should be discontinued until the cause of eye inflammation associated with the medication is identified [4].
• February 2020 – The American Society of Retina Specialists released a safety update detailing 14 cases of retinal inflammation in patients who had received brolucizumab injections, with 11 cases involving occlusive retinal vasculitis that can lead to blindness [5].

Beovu Injuries & Side Effects

Patients taking Beovu may experience severe vision-threatening complications that have led to numerous lawsuits against the manufacturer.

Serious side effects include:

• Vision Problems: Severe vision loss and peripheral vision loss
• Retinal Complications: Retinal vasculitis, retinal vein occlusion, and retinal artery occlusion
• Inflammatory Conditions: Intraocular inflammation and chronic eye disorders
• Permanent Damage: Blindness and irreversible vision impairment

Additional adverse events may include:

• Blurred vision
• Cataracts
• Bleeding in the eye
• Eye pain
• Eye “floaters”
• Do You Qualify for a Beovu Lawsuit?

You may qualify for a Beovu lawsuit if:

• You received Beovu injections for wet AMD treatment
• You experienced serious side effects including retinal vasculitis, retinal artery occlusion, intraocular inflammation, or severe vision loss
• The injuries required medical treatment or hospitalization
• You can provide medical documentation linking your injuries to Beovu injections

Evidence Required for a Beovu Lawsuit

To pursue a successful Beovu lawsuit, you will need:

• Medical records documenting your wet AMD diagnosis and treatment
• Documentation of Beovu injections received
• Medical records showing vision complications following treatment
• Ophthalmological examination results
• Any imaging tests (angiographic imaging, retinal photographs)

Damages You Can Recover

If you developed retinal vasculitis, retinal artery occlusion, intraocular inflammation, or other vision problems after receiving Beovu injections, you may be entitled to:

• Past and future medical expenses to treat your injuries
• Past and future pain and suffering that results from your injuries
• Lost wages
• Other economic losses experienced because of your injuries
• Punitive damages, if appropriate

Statute of Limitations for Beovu Lawsuits

The statute of limitations for filing a Beovu lawsuit varies by state, typically ranging from one to six years from the date of injury or discovery of the injury. In product liability cases involving pharmaceuticals, many states allow the statute of limitations to begin when the patient discovers or reasonably should have discovered that their injury was caused by the medication. Given the complexity of these cases and the variation in state laws, it is crucial to consult with an experienced attorney as soon as possible to ensure your claim is filed within the applicable time limits.

FAQs

1. Why are there lawsuits related to Beovu?

There are lawsuits related to Beovu because these lawsuits allege that Beovu is associated with serious side effects, including vision-threatening complications such as retinal vasculitis and retinal occlusion. The plaintiffs claim that the manufacturer did not adequately disclose these adverse effects.

2. What are the common side effects of Beovu?

The common side effects of Beovu include eye pain, redness, and blurred vision. More severe complications, reported in some lawsuits, involve retinal inflammation, blood clots, and loss of vision.

3. Who can file a lawsuit related to Beovu?

Individuals who have experienced severe side effects or complications after using Beovu, such as significant vision loss or other serious health issues, can file a lawsuit related to Beovu. It is advisable to consult with a legal professional to determine eligibility.

4. Is Beovu still on the market?

No, Beovu is no longer on the market. Although the intravitreal injection drug has been available for less than two years, its history has been marked by significant controversy and legal challenges.

5. Has a class action been filed for Beovu?

To date, there have been no large class action Beovu lawsuits. This is because Beovu is a new drug and litigation like this takes many years to resolve, with teams of lawyers spending millions of dollars trying to determine exactly what occurred, and how it could have been prevented.

6. Has Beovu been recalled?

To date, Beovu has not been recalled and continues to be prescribed to thousands of unsuspecting patients around the country. While the U.S. Food and Drug Administration approved Novartis’ label change, it did not issue a safety communication to the public or announce any regulatory actions.

7. What is retinal vasculitis and how does it relate to Beovu?

Vasculitis of the eye is caused by inflammation of blood vessels in the retina (retinal vasculitis). Retinal vasculitis ranges in severity from mild to severe and can cause partial or complete blindness. According to safety data, 2.1% of Beovu patients developed occlusive vasculitis, with a 1 in 5 risk of at least six-line vision loss.

8. What compensation could I be awarded in a Beovu lawsuit?

Compensation may include past and future medical expenses, pain and suffering, lost wages, other economic losses, and potentially punitive damages depending on the severity of your injuries and the circumstances of your case.

Related Article: Qui Tam Lawsuit & Whistleblower Info

Get a Free Beovu Lawsuit Evaluation With Our Lawyers

The Pharmaceutical Liability Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Beovu Lawsuits. We are handling individual litigation nationwide and currently accepting new Beovu lawsuits in all 50 states.

Our legal team offers:

• Free, confidential consultations to evaluate your case
• No upfront costs or fees – we only get paid if we win your case
• Experienced pharmaceutical litigation attorneys
• Nationwide representation for Beovu injury cases

References:

1. https://www.novartis.com/news/media-releases/european-medicines-agency-ema-approves-safety-label-update-novartis-beovu
2. https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2768911
3. https://pmc.ncbi.nlm.nih.gov/articles/PMC7418897/
4. https://pmc.ncbi.nlm.nih.gov/articles/PMC7263271/
5. https://www.ophthalmologyretina.org/article/S2468-6530(20)30400-0/fulltext